Northern Trust Corp Kiniksa Pharmaceuticals, Ltd. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$17.63 - $21.74 $167,132 - $206,095	-9,480 Reduced 3.16%	290,644 $5.73 Million
Q4 2023 Feb 13, 2024	BUY	$14.37 - $19.07 $57,551 - $76,375	4,005 Added 1.35%	300,124 $5.26 Million
Q3 2023 Nov 13, 2023	BUY	$13.62 - $20.2 $106,808 - $158,408	7,842 Added 2.72%	296,119 $5.14 Million
Q2 2023 Aug 11, 2023	SELL	$10.44 - $16.48 $40,120 - $63,332	-3,843 Reduced 1.32%	288,277 $4.06 Million
Q1 2023 May 15, 2023	BUY	$10.7 - $15.79 $58,261 - $85,976	5,445 Added 1.9%	292,120 $3.14 Million
Q4 2022 Feb 13, 2023	BUY	$11.42 - $17.05 $174,052 - $259,859	15,241 Added 5.61%	286,675 $4.29 Million
Q3 2022 Nov 14, 2022	SELL	$9.76 - $13.41 $37,780 - $51,910	-3,871 Reduced 1.41%	271,434 $3.49 Million
Q2 2022 Aug 12, 2022	BUY	$7.6 - $11.41 $55,176 - $82,836	7,260 Added 2.71%	275,305 $2.67 Million
Q1 2022 May 13, 2022	SELL	$9.3 - $12.37 $117,059 - $155,701	-12,587 Reduced 4.49%	268,045 $2.66 Million
Q4 2021 Feb 08, 2022	BUY	$10.39 - $15.15 $63,108 - $92,021	6,074 Added 2.21%	280,632 $3.3 Million
Q3 2021 Nov 15, 2021	SELL	$11.39 - $16.23 $132,579 - $188,917	-11,640 Reduced 4.07%	274,558 $3.13 Million
Q2 2021 Aug 13, 2021	SELL	$13.22 - $19.09 $173,406 - $250,403	-13,117 Reduced 4.38%	286,198 $3.99 Million
Q1 2021 May 12, 2021	SELL	$16.68 - $23.97 $228,299 - $328,077	-13,687 Reduced 4.37%	299,315 $5.54 Million
Q4 2020 Feb 11, 2021	SELL	$14.8 - $21.15 $20,868 - $29,821	-1,410 Reduced 0.45%	313,002 $5.53 Million
Q3 2020 Nov 16, 2020	BUY	$15.21 - $25.53 $1.18 Million - $1.98 Million	77,402 Added 32.66%	314,412 $4.82 Million
Q2 2020 Aug 14, 2020	BUY	$15.08 - $26.0 $916,773 - $1.58 Million	60,794 Added 34.5%	237,010 $6.04 Million
Q1 2020 May 14, 2020	BUY	$11.0 - $19.76 $308,088 - $553,438	28,008 Added 18.9%	176,216 $2.73 Million
Q4 2019 Feb 14, 2020	SELL	$5.24 - $12.96 $80,198 - $198,352	-15,305 Reduced 9.36%	148,208 $1.64 Million
Q3 2019 Nov 13, 2019	BUY	$8.15 - $15.88 $70,204 - $136,790	8,614 Added 5.56%	163,513 $1.39 Million
Q2 2019 Aug 13, 2019	BUY	$13.2 - $20.39 $298,914 - $461,731	22,645 Added 17.12%	154,899 $2.1 Million
Q1 2019 May 13, 2019	BUY	$15.93 - $26.59 $854,963 - $1.43 Million	53,670 Added 68.3%	132,254 $2.39 Million
Q4 2018 Feb 12, 2019	SELL	$16.25 - $28.09 $5,817 - $10,056	-358 Reduced 0.45%	78,584 $2.21 Million
Q3 2018 Nov 14, 2018	BUY	$13.23 - $30.93 $1.04 Million - $2.44 Million	78,942 New	78,942 $2.01 Million

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$30.2 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$4.04 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

98.1K
Shares

$1.95 Million
0.08% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$786,955
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$597,900
0.69% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account